Ameliorating the effect and mechanism of chitosan oligosaccharide on nonalcoholic fatty liver disease in mice

文献情報

出版日 2023-11-03
DOI 10.1039/D3FO03745B
インパクトファクター 5.396
著者

Yan Bai, Qishi Che, Hua Cao, Jiao Guo, Zhengquan Su


原文を見る

要旨

Previous studies have found that chitosan oligosaccharide (COST) can alleviate the clinical symptoms in non-alcoholic fatty liver disease (NAFLD) patients. We intend to intervene with different concentrations of COST in mice with NAFLD induced by a high fat diet. The basic effect of COST on NAFLD model mice was observed using physiological and biochemical indexes. 16S rRNA sequencing technology was used to analyze the gut microbiota and further analyze the content of short-chain fatty acids (SCFAs). Western blot and RT-PCR were used to detect the effects of COST on the PI3K/AKT/mTOR signaling pathway in the livers of NAFLD mice. It was found that the COST-high-dose group could reduce the weight of NAFLD mice, improve dyslipidemia, and alleviate liver lesions, and COST has a therapeutic effect on NAFLD mice. 16S rRNA sequencing analysis showed that COST could increase the diversity of the gut microbiota in NAFLD mice. The downregulation of SCFAs in NAFLD mice was reversed. WB and RT-PCR results showed that the PI3K/AKT/mTOR signaling pathway was involved in the development of NAFLD mice. COST improved liver lipid metabolism in NAFLD mice by inhibiting liver DNL. COST could increase the expression of thermogenic protein and UCP1 and PGC-1α genes; the PI3K/AKT/mTOR signaling pathway is inhibited at the protein and gene levels. This study revealed that COST regulates the expression of related inflammatory factors caused by lipid toxicity through the gut microbiota and SCFAs, and improves the liver lipid metabolism of HFD-induced NAFLD mice, laying a foundation for the development of effective and low toxicity drugs for the treatment of NAFLD.

関連文献

Morphology – composition correlations in carbon nanotubes synthesised with nitrogen and phosphorus containing precursors

Rebecca J. Nicholls, Zabeada Aslam, Michael C. Sarahan, Ana M. Sanchez, Frank Dillon, Antal A. Koós, Nicole Grobert

2014-11-21 Paper

DOI: 10.1039/C4CP04272G

Optimal top electrodes for inverted polymer solar cells

Hye Rim Yeom, Jungwoo Heo, Gi-Hwan Kim, Seo-Jin Ko, Seyeong Song, Yimhyun Jo, Dong Suk Kim, Bright Walker, Jin Young Kim

2014-11-27 Paper

DOI: 10.1039/C4CP04788E

Revisiting the conundrum of trehalose stabilization

Nidhi Katyal, Shashank Deep

2014-10-28 Paper

DOI: 10.1039/C4CP02914C

Durability, inactivation and regeneration of silver tetratantalate in photocatalytic H2 evolution

Gang Chen, Jingxue Sun, Chunmei Li, Chade Lv, Yidong Hu

2014-11-11 Communication

DOI: 10.1039/C4CP04273E

Electronic structures at the interface between Au and CH3NH3PbI3

Xiaoliang Liu, Chenggong Wang, Lu Lyu, Congcong Wang, Zhengguo Xiao, Cheng Bi, Jinsong Huang, Yongli Gao

2014-11-07 Paper

DOI: 10.1039/C4CP03842H

Energetic contributions of residues to the formation of early amyloid-β oligomers

R. Pouplana, J. M. Campanera

2014-12-05 Paper

DOI: 10.1039/C4CP04544K

Alkane separation using nanoporous graphene membranes

Krzysztof Nieszporek, Mateusz Drach

2014-11-11 Paper

DOI: 10.1039/C4CP02745K

Origin of surface trap states in CdS quantum dots: relationship between size dependent photoluminescence and sulfur vacancy trap states

Aisea Veamatahau, Bo Jiang, Tom Seifert, Satoshi Makuta, Kay Latham, Masayuki Kanehara, Toshiharu Teranishi

2014-12-05 Paper

DOI: 10.1039/C4CP04761C

こちらもおすすめ

化合物よくある質問

1-{3-[5-(エチルカルボンイル)-2,4-ジメチル-1H-ピロロール-3-基]プロパニル}ピペリジン-4-カルボン酸について、適用される法規ガイドラインは何ですか?

この化合物はCAS番号1142209-81-1であり、GHS分類では corrosive (腐食性物質) と classified (分類物質) として指定され...

1142209-81-11-{3-[5-(Ethoxycarbo...
化合物よくある質問

2,2-二氟-1,3-ベンゾジオキサン-5-カルボキシlic酸とは何ですか?

2,2-二氟-1,3-ベンゾジオキサン-5-カルボキシlic酸は、CAS番号656-46-2の化合物で、化学式はC8H4F2O4です。この化合物は白色の結晶性粉...

656-46-22,2-Difluoro-1,3-ben...
化合物よくある質問

8-氯-4-色原酮の代替品はありますか?

8-氯-4-色原酮(CAS番号: 49701-11-3)の代替品には、他の色原酮類似物や、構造が似ている化合物があります。例えば、8-メチル-4-色原酮や、他の...

49701-11-38-Chloro-2,3-dihydro...
化合物よくある質問

エチル6,6-ジメチル-4,5,6,7-テトラヒドロ-1H-インドアゼー-3-カルボキシレートとは何ですか?

エチル6,6-ジメチル-4,5,6,7-テトラヒドロ-1H-インドアゼー-3-カルボキシレートは、CAS番号1233243-56-5を有する化合物です。これは有...

1233243-56-5Ethyl 6,6-dimethyl-4...
化合物よくある質問

4-叔丁基-6-氯-嘧啶に適用される法規ガイドラインは何ですか?

4-叔丁基-6-氯-嘧啶はCAS番号3435-24-3で、GHS分類では毒性物質とみなし、GHSの危険性分類が適用されます。REACH規則では登録が必要で、Eu...

3435-24-34-Tert-butyl-6-chlor...
化合物よくある質問

維库溴铵杂质Bはどのように合成されますか?

維库溴铵杂质Bは、アンドロステンデンから始まり、一連の合成反応、包括的な選択性と高い収率で合成されます。具体的には、ブロミド化、酸化、ジマーゼ反応、アミド化など...

50587-95-6(2beta,3alpha,5alpha...
化合物よくある質問

2-(4-氟苄基)-吡咯烷の物理化学的性質は何ですか?

CAS番号350017-04-8の2-(4-氟苄基)-吡咯烷は、結晶性の白色粉末です。分子量は199.17 g/molで、水に溶けにくいです。化学反応では比較的...

350017-04-82-(4-Fluorobenzyl)py...
化合物よくある質問

3-喹啉甲醛(2-チロール-8-エチル)は安全ですか?

3-喹啉甲醛(2-チロール-8-エチル)は一定の毒性を持つため、取扱には注意が必要です。使用する際は適切な防護具を着用し、密閉容器で保管・搬送し、直接的な接触を...

335196-05-92-Chloro-8-ethyl-3-q...
化合物よくある質問

エチル3-(ヒドロキシメチル)-1H-ピロール-2-カルボキシレートはどのように保存すればよいですか?

エチル3-(ヒドロキシメチル)-1H-ピロール-2-カルボキシレートは、室温(25℃)以下で保存し、直射日光を避け、乾燥した環境で保管することが推奨されます。ま...

75448-69-0Ethyl 3-(hydroxymeth...
化合物よくある質問

哌拉西林杂质Dは安全ですか?

哌拉西林杂质Dは安全性が確認されていません。使用または取り扱いには注意が必要で、適切な個人防護具を使用し、直接的な接触を避けることが推奨されます。

119410-05-88-Chloro-11-(4-piper...

掲載誌

Food & Function

Food & Function
CiteScore: 10.1
自己引用率: 3.9%
年間論文数: 758

Food & Function provides a unique venue for physicists, chemists, biochemists, nutritionists and other food scientists to publish novel, cutting-edge, original research focussing on food, its nutrients and their relation to human health and nutrition. We welcome research describing the: Physical properties and structure of food and how this relates to sensory perception and human health Biochemical and physiological actions of food components Interactions between foods, gut microbiota and human physiology Nutritional and biological evaluation of food Clinical and population studies using food or food components Development of biomarkers of food intake and effects on human health We also welcome systematic reviews and meta-analyses of existing studies in the literature, provided these are objective and scientifically valid Food in this context is defined as materials of plant, animal or mineral origin, which are consumed orally (by humans) for pleasure and to sustain growth and vital processes. Examples of research topics that are of interest to be published in Food & Function are: Chemistry and physics of food components and digestion processes Relationship between the physical properties/structure of food and nutrition and human health - for example, impact of food matrix or processing on nutrient release and uptake Molecular properties and physiological effects of food components (nutrients, fibres, essential micronutrients, phytochemicals, bioactives, food substitutes, novel ingredients, allergens, flavours and fragrances) Nutritional and health effects of food including bioavailability and metabolism assessment of food components (nutrients, micronutrients and other microconstituents) Efficacy and mechanisms of food constituents in the body - including biomarkers of intakes, exposure and effects Impacts of foods/food components on gut microorganisms and human physiology - For example impact of fermented foods Role of nutrition and diet in human disease prevention and development Cellular and molecular effects/mechanisms of food/food components image block The following types of research are not within the scope of Food & Function: Research relating to traditional herbal medicines, medicinal plants or active compounds extracted from such plants (materials that are primarily consumed as medicine, i.e. the intended purpose is primarily to treat, cure or prevent a non-deficiency disease) or relating to foods not recognised as human diet contributors Animal nutrition research that is not primarily designed as a model to benefit human nutrition (for example, studies of growth/accretion, heat stress, weaning, ruminant digestion, meat quality, etc.) Treatments administered by non-oral routes such as injection (subcutaneous, intramuscular, intraperitoneal, etc.), dermal/transdermal, rectal, inhalation, nasal, etc. Exceptions are when such routes of administration are used for mechanistic/control purposes in the experimental design Pharmacological/pharmaceutical approaches: Encapsulation, emulsification and/or pure controlled release of compounds or bioactives that do not come directly from edible foods, such as dietary supplements - these are better suited to a pharmaceutical journal In vitro or in vivo studies with poorly defined (insufficiently characterised) extracts and studies without appropriate controls will not be considered Cells studies not considering the metabolism of food components ingested – for example, irrelevant exposure of cells to compounds not present in the body after absorption Manuscripts with only a fully theoretical/bioinformatic approach and without appropriate support from analytical evidence will not be considered for publication Studies focussing solely on food engineering, preservation and sustainable technologies – these can be published in our companion journal Sustainable Food Technology Pure food analysis - these can be published in Analytical Methods

おすすめ化合物

おすすめサプライヤー

免責事項
このページに表示される学術雑誌情報は、参考および研究目的のみを目的としています。当社は雑誌出版社とは提携しておらず、投稿の取り扱いも行っておりません。出版に関するお問い合わせは、各雑誌出版社に直接ご連絡ください。
表示されている情報に誤りがある場合は、support@chemtradehub.com までご連絡ください。迅速に確認し、対応いたします。